help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Willheim, M.
Right arrow Articles by Peterlik, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Willheim, M.
Right arrow Articles by Peterlik, M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*1,25-DIHYDROXYCHOLECALCIFEROL
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 10 3739-3744
Copyright © 1999 by The Endocrine Society


Original Studies

Regulatory Effects of 1{alpha},25-Dihydroxyvitamin D3 on the Cytokine Production of Human Peripheral Blood Lymphocytes1

Martin Willheim2, Ralf Thien2, Karl Schrattbauer, Erika Bajna, Margareta Holub, Reinhard Gruber, Karin Baier, Peter Pietschmann, Walter Reinisch, Otto Scheiner and Meinrad Peterlik

Institute of General and Experimental Pathology (M.W., R.T., K.S., E.B., M.H., R.G., K.B., P.P., O.S., M.P.) and the Department of Gastroenterology and Hepatology (W.R.), Clinic of Internal Medicine IV, University of Vienna, Vienna, Austria

Address all correspondence and requests for reprints to: Martin Willheim, M.D., Institute of General and Experimental Pathology, AKH Wien, Waehringer Guertel 18–20, A-1090 Vienna, Austria. E-mail: martin.willheim{at}akh-wien.ac.at

We studied the possible regulatory effects of 1{alpha},25-dihydroxyvitamin D3 [1{alpha},25-(OH)2D3] on cytokine production and differentiation of subsets of CD4+ [T helper 1 (Th1) and Th2] and CD8+ [T cytotoxic 1 (Tc1) and Tc2] lymphocytes at the single cell level. PBMC from healthy donors were cultured with or without 1{alpha},25-(OH)2D3 for up to 21 days. On days 0, 7, 14, and 21, the percentage of cytokine-producing T lymphocytes was analyzed by intracellular cytokine detection with mAb and flow cytometry. Simultaneous staining for cell surface markers allowed discrimination of CD4+ and CD8+ T cell subsets. After culture with 1{alpha},25-(OH)2D3 (10-8 mol/L), no significant effects on the proportion of interferon-{gamma} (IFN{gamma})- or interleukin-4 (IL-4)-producing cells were detected, whereas reduced frequencies of IL-2-producing cells in the CD4+ as well as in the CD8+ population were found. An increase in the low percentage of CD4+ and CD8+ T cells producing the Th2 cytokine IL-13 was noticed. Most interestingly, IL-6-producing CD4+ and CD8+ T cells could only be detected in cultures with 1{alpha},25-(OH)2D3, reaching a plateau after 14 days. The percentage of IL-6-producing T cells induced by 1{alpha},25-(OH)2D3 after a given time period remained stable for at least 7 weeks. Studies of cytokine coexpression revealed that about 70% of IL-6-producing CD4+ and CD8+ cells were also positive for IL-2, but more than 90% were negative for IFN{gamma}, IL-4, or IL-13, respectively. This suggests that the IL-6-producing population does not match the Th1/Tc1-like (IFN{gamma}+) or Th2/Tc2-like (IL-4+ or IL-13+) subset. The influence of 1{alpha},25-(OH)2D3 on cytokine production by lymphocytes is probably an important point of intersection between the endocrine and the immune system.




This article has been cited by other articles:


Home page
Diabetes CareHome page
M. Cigolini, M. P. Iagulli, V. Miconi, M. Galiotto, S. Lombardi, and G. Targher
Serum 25-hydroxyvitamin d3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients.
Diabetes Care, March 1, 2006; 29(3): 722 - 724.
[Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. F. Meehan and H. F. DeLuca
CD8+ T cells are not necessary for 1alpha ,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice
PNAS, April 16, 2002; 99(8): 5557 - 5560.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. F. Meehan and H. F. DeLuca
CD8+ T cells are not necessary for 1alpha ,25-dihydroxyvitamin D3 to suppress experimental autoimmune encephalomyelitis in mice
PNAS, April 16, 2002; 99(8): 5557 - 5560.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society